193 Stewardship Role in the Periprocedural Management of Patients with Hemophilia A Before and After Introduction of Emicizumab
Saved in:
| Main Authors: | Daniel Cartagena-Sergenian, Dareen M. Kanaan, Katelyn W. Sylvester, Jean M. Connors, Nathan T. Connell |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Research and Practice in Thrombosis and Haemostasis |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2475037925000895 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
135 Real World Experience with Use of Coagulation Factor VIIa (Recombinant)-jncw (SevenFact®) at an Academic Medical Center
by: Alyssa R. George, et al.
Published: (2025-05-01) -
PO65 | Utilization of emicizumab in acquired hemophilia A: a case report
Published: (2025-08-01) -
PO86 | Emicizumab in patients with moderate hemophilia A and severe bleeding phenotype: single-center real-world experience
Published: (2025-08-01) -
PO55 | Evaluation of safety and efficacy of emicizumab prophylaxis in pediatric patients with hemophilia A – a single centre experience
Published: (2025-08-01) -
CO34 | Evaluation of emicizumab concentration and thrombin generation in a cohort of severe hemophilia A patients with and without inhibitor
Published: (2025-08-01)